SSY Group Ltd., (LJUIF,2005.HK), a Chinese pharmaceutical manufacturer, reported Friday lower profit in fiscal 2025 with weak revenues. The company also announced a cut in dividend.
In Hong Kong, the shares were trading at HK$2.420, up 1.26 percent.
In fiscal 2025, net profit attributable to Equity shareholders of the Company HK$470.64 million, down 55.6 percent from HK$1.06 billion.
Earnings per share were HK$0.1605, compared to prior year's HK$0.3581.
Revenue was approximately HK$4.17 billion, decrease of 27.8 percent from HK$5.77 billion a year ago.
In terms of Renminbi, the company achieved a revenue of around RMB3.81 billion, representing a decrease of 27.6 percent as compared to last year.
Further, the Board recommended a final dividend of HK$0.03 per share, down from HK$0.095 per share last year, payable on June 4 to the shareholders in the register of members on May 21.
Total dividend for the year was HK$0.08 per share, representing a decrease of 54.3 percent as compared to last year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.